Remission of primary pulmonary hypertension during treatment with diazoxide.
作者信息
Hall D R
出版信息
Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1118. doi: 10.1136/bmj.282.6270.1118.
Abstract
摘要
相似文献
1
Remission of primary pulmonary hypertension during treatment with diazoxide.
Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1118. doi: 10.1136/bmj.282.6270.1118.
2
Diazoxide in primary pulmonary hypertension.
N Engl J Med. 1980 Jan 10;302(2):91-2. doi: 10.1056/NEJM198001103020204.
3
Hope in primary pulmonary hypertension.
N Engl J Med. 1980 Jan 10;302(2):112-3. doi: 10.1056/NEJM198001103020210.
4
Diazoxide in treatment of primary pulmonary hypertension.
Br Heart J. 1978 May;40(5):572-4. doi: 10.1136/hrt.40.5.572.
5
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
Br Heart J. 1987 Feb;57(2):207-9. doi: 10.1136/hrt.57.2.207.
6
Vasodilator therapy for pulmonary hypertension.
N Engl J Med. 1980 May 29;302(22):1260. doi: 10.1056/NEJM198005293022213.
7
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
Br Heart J. 1987 Oct;58(4):420. doi: 10.1136/hrt.58.4.420-a.
8
Diazoxide in treatment of primary pulmonary hypertension.
Br Heart J. 1979 Sep;42(3):362-3. doi: 10.1136/hrt.42.3.362.
9
Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.
Thorax. 1980 Apr;35(4):269-76. doi: 10.1136/thx.35.4.269.
10
[Primary pulmonary arterial hypertension. Trial treatment with nifedipine, diazoxide and isoproterenol].
Nouv Presse Med. 1980 Dec 20;9(48):3698-9.
引用本文的文献
1
How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension.
Pulm Circ. 2025 Feb 26;15(1):e70059. doi: 10.1002/pul2.70059. eCollection 2025 Jan.
2
Rapid recurrence of pulmonary hypertension following cessation of nifedipine.
Postgrad Med J. 1998 Feb;74(868):111-2. doi: 10.1136/pgmj.74.868.111.
3
Vasodilator therapy of pulmonary hypertension in the CRST syndrome.
Ir J Med Sci. 1982 May;151(5):151-4. doi: 10.1007/BF02940166.
4
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
Br Heart J. 1987 Feb;57(2):207-9. doi: 10.1136/hrt.57.2.207.
5
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
Br Heart J. 1987 Oct;58(4):420. doi: 10.1136/hrt.58.4.420-a.
6
Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.
Br Med J (Clin Res Ed). 1988 Jan 9;296(6615):111-5. doi: 10.1136/bmj.296.6615.111.
本文引用的文献
1
Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance.
Bull N Y Acad Med. 1954 Mar;30(3):195-207.
2
Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.
Thorax. 1980 Apr;35(4):269-76. doi: 10.1136/thx.35.4.269.
3
Oral hydralazine therapy for primary pulmonary hypertension.
N Engl J Med. 1980 Jan 10;302(2):69-73. doi: 10.1056/NEJM198001103020201.
4
Primary pulmonary hypertension; favorable effect of isoproterenol.
N Engl J Med. 1976 Dec 16;295(25):1414-5. doi: 10.1056/NEJM197612162952506.
5
Diazoxide in treatment of primary pulmonary hypertension.
Br Heart J. 1978 May;40(5):572-4. doi: 10.1136/hrt.40.5.572.
Zotero 插件